• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物组在糖尿病中的作用。

The role of the microbiome in diabetes mellitus.

机构信息

Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of Endocrinology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

出版信息

Diabetes Res Clin Pract. 2021 Feb;172:108645. doi: 10.1016/j.diabres.2020.108645. Epub 2020 Dec 24.

DOI:10.1016/j.diabres.2020.108645
PMID:33359751
Abstract

The microbiome is greatly significant for immune system development and homeostasis. Dysbiosis in gut microbial composition and function is linked to immune responses and the development of metabolic diseases, including diabetes mellitus (DM). However, skin microbiome changes in diabetic patients and their role in DM are poorly elucidated. In this review, we summarize recent findings about the association between the gut and skin microbiota and DM, highlighting their roles in the proinflammatory status of DM. Moreover, although there is evidence that the connection between the gut and skin causes the same activated innate immune response, additional studies are needed to explore the mechanism. These findings might inform future DM prevention, diagnosis and treatment.

摘要

微生物组对于免疫系统的发育和稳态具有重要意义。肠道微生物组成和功能的失调与免疫反应和代谢疾病(包括糖尿病)的发展有关。然而,糖尿病患者的皮肤微生物组变化及其在糖尿病中的作用仍不清楚。在这篇综述中,我们总结了肠道和皮肤微生物组与糖尿病之间的关联的最新发现,强调了它们在糖尿病促炎状态中的作用。此外,尽管有证据表明肠道和皮肤之间的联系会引起相同的固有免疫激活反应,但仍需要更多的研究来探索其机制。这些发现可能为未来的糖尿病预防、诊断和治疗提供信息。

相似文献

1
The role of the microbiome in diabetes mellitus.微生物组在糖尿病中的作用。
Diabetes Res Clin Pract. 2021 Feb;172:108645. doi: 10.1016/j.diabres.2020.108645. Epub 2020 Dec 24.
2
Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes.肠道免疫调节细胞(T 淋巴细胞):肠道菌群与糖尿病之间的桥梁。
Mediators Inflamm. 2018 Mar 11;2018:9830939. doi: 10.1155/2018/9830939. eCollection 2018.
3
Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.理解活检证实的糖尿病肾病、2 型糖尿病和健康对照组之间的肠-肾轴:肠道微生物组组成的分析。
Acta Diabetol. 2019 May;56(5):581-592. doi: 10.1007/s00592-019-01316-7. Epub 2019 Mar 19.
4
Interaction between the gut microbiome and mucosal immune system.肠道微生物组与黏膜免疫系统的相互作用。
Mil Med Res. 2017 Apr 27;4:14. doi: 10.1186/s40779-017-0122-9. eCollection 2017.
5
Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?肠道微生物群:糖尿病视网膜病变管理的潜在治疗靶点?
Life Sci. 2021 Dec 1;286:120060. doi: 10.1016/j.lfs.2021.120060. Epub 2021 Oct 16.
6
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.了解肠道微生物组和微生物代谢产物在肥胖及肥胖相关代谢紊乱中的作用:当前的证据和观点。
Curr Obes Rep. 2019 Sep;8(3):317-332. doi: 10.1007/s13679-019-00352-2.
7
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.肠道微生物群及其代谢产物在肠道稳态和人类疾病中的作用。
BMC Immunol. 2017 Jan 6;18(1):2. doi: 10.1186/s12865-016-0187-3.
8
The Gut-Skin Microbiota Axis and Its Role in Diabetic Wound Healing-A Review Based on Current Literature.肠道-皮肤微生物群轴及其在糖尿病伤口愈合中的作用——基于当前文献的综述
Int J Mol Sci. 2022 Feb 21;23(4):2375. doi: 10.3390/ijms23042375.
9
Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy.证据表明肠道菌群失调在糖尿病视网膜病变中的作用。
Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):21. doi: 10.1167/iovs.63.8.21.
10
The crucial role of early-life gut microbiota in the development of type 1 diabetes.早期肠道微生物群在 1 型糖尿病发展中的关键作用。
Acta Diabetol. 2021 Mar;58(3):249-265. doi: 10.1007/s00592-020-01563-z. Epub 2020 Jul 25.

引用本文的文献

1
Physiological Mechanisms of and Therapeutic Approaches to the Gut Microbiome and Low-Grade Inflammation in Obesity.肥胖症中肠道微生物群与低度炎症的生理机制及治疗方法
Curr Issues Mol Biol. 2025 Aug 8;47(8):637. doi: 10.3390/cimb47080637.
2
Dual-approach analysis of gut microbiome in patients with type 1 diabetes and diabetic kidney disease.1型糖尿病和糖尿病肾病患者肠道微生物群的双方法分析
Ann Med. 2025 Dec;57(1):2531254. doi: 10.1080/07853890.2025.2531254. Epub 2025 Jul 26.
3
Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis.
植物乳杆菌LRCC5195副益生菌通过微生物群调节对特应性皮炎的缓解作用及基于基因组特征和体外分析的安全性评估
Sci Rep. 2025 Aug 20;15(1):30545. doi: 10.1038/s41598-025-16102-5.
4
Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.鼠李糖乳杆菌通过抗炎分子减轻非透析慢性肾病患者体内的尿毒症毒素。
Sci Rep. 2025 Jul 31;15(1):27990. doi: 10.1038/s41598-025-12768-z.
5
Analysis of nasal secretion culture results in diabetic patients with chronic rhinosinusitis and factors influencing postoperative recurrence.糖尿病合并慢性鼻-鼻窦炎患者鼻分泌物培养结果及影响术后复发因素分析
World J Diabetes. 2025 Jul 15;16(7):104970. doi: 10.4239/wjd.v16.i7.104970.
6
Illuminating diabetes multi-omics: Unraveling disease mechanisms and advancing personalized therapy.解读糖尿病多组学:揭示疾病机制与推进个性化治疗
World J Diabetes. 2025 Jul 15;16(7):106218. doi: 10.4239/wjd.v16.i7.106218.
7
Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification.追踪糖尿病肾病的分子图谱:机器学习与实验验证的见解
J Diabetes Investig. 2025 Aug;16(8):1473-1486. doi: 10.1111/jdi.70026. Epub 2025 Jun 5.
8
The effect of the administration form of antibiotic therapy on the gut microbiome in patients with infected diabetic foot ulcers - DFIATIM trial.抗生素治疗给药形式对感染性糖尿病足溃疡患者肠道微生物群的影响——DFIATIM试验
BMC Microbiol. 2025 May 28;25(1):339. doi: 10.1186/s12866-025-04041-0.
9
New insights in the treatment of DKD: recent advances and future prospects.糖尿病肾病治疗的新见解:近期进展与未来展望。
BMC Nephrol. 2025 Feb 11;26(1):72. doi: 10.1186/s12882-025-03953-3.
10
Elucidating the causal relationship between gut microbiota, metabolites, and diabetic nephropathy in European patients: Revelations from genome-wide bidirectional mendelian randomization analysis.阐明欧洲患者肠道微生物群、代谢物与糖尿病肾病之间的因果关系:全基因组双向孟德尔随机化分析的启示
Front Endocrinol (Lausanne). 2025 Jan 8;15:1391891. doi: 10.3389/fendo.2024.1391891. eCollection 2024.